Zelong

Zelong Ma is a senior scientist at EpimAb Biotherapeutics, Inc. since May 2018, specializing in antibody discovery and the mRNA-LNP immunization platform. Previous experience includes serving as a Scientist II, focusing on antibody discovery through animal immunization, hybridoma generation, high-throughput screening, and mRNA vaccine research. Prior roles at Shanghai Genechem and Shanghai Hengrui Pharmaceutical Company involved significant contributions to CAR-T cell research and enzyme inhibitor screening, respectively. Zelong Ma holds a Master's degree in Biochemistry and Molecular Biology from Sichuan University, completed in 2014.